Atezolizumab vs Single-Agent Chemo in NSCLC Patients Ineligible for a 1L Platinum Regimen: Asian Subgroup Analysis of IPSOS

Lee, S. M. and Han, B. and Peters, S. and Le, A. T. and Huang, D. and Wu, G. and Cao, L. and Pham, C. P. and Zhao, J. and Wang, K. and Yang, N. and Zhong, H. and Hu, Y. and Morris, S. and Lam, V. and Graupner, V. and Gitlitz, B. and Hoglander, E. and Schulz, C. (2023) Atezolizumab vs Single-Agent Chemo in NSCLC Patients Ineligible for a 1L Platinum Regimen: Asian Subgroup Analysis of IPSOS. In: 2023 World Conference on Lung Cancer, 09 September 2023 - 12 September 2023, Singapore.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Uncontrolled Keywords: IPSOS; Atezolizumab; Asian subgroup
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 01 Feb 2024 11:05
Last Modified: 01 Feb 2024 11:05
URI: https://pred.uni-regensburg.de/id/eprint/60624

Actions (login required)

View Item View Item